- Home
- CNTA vs EVCM Comparison
CNTA vs EVCM Comparison
Compare CNTA & EVCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTA
- EVCM
- Stock Information
- Founded
- CNTA 2020
- EVCM 2006
- Country
- CNTA United Kingdom
- EVCM United States
- Employees
- CNTA N/A
- EVCM N/A
- Industry
- CNTA Biotechnology: Pharmaceutical Preparations
- EVCM EDP Services
- Sector
- CNTA Health Care
- EVCM Technology
- Exchange
- CNTA Nasdaq
- EVCM Nasdaq
- Market Cap
- CNTA 2.3B
- EVCM 2.1B
- IPO Year
- CNTA 2021
- EVCM 2021
- Fundamental
- Price
- CNTA $21.81
- EVCM $11.85
- Analyst Decision
- CNTA Strong Buy
- EVCM Buy
- Analyst Count
- CNTA 11
- EVCM 9
- Target Price
- CNTA $30.60
- EVCM $11.89
- AVG Volume (30 Days)
- CNTA 1.5M
- EVCM 249.0K
- Earning Date
- CNTA 11-11-2025
- EVCM 11-11-2025
- Dividend Yield
- CNTA N/A
- EVCM N/A
- EPS Growth
- CNTA N/A
- EVCM N/A
- EPS
- CNTA N/A
- EVCM N/A
- Revenue
- CNTA $15,000,000.00
- EVCM $710,678,000.00
- Revenue This Year
- CNTA N/A
- EVCM N/A
- Revenue Next Year
- CNTA N/A
- EVCM $5.95
- P/E Ratio
- CNTA N/A
- EVCM N/A
- Revenue Growth
- CNTA 118.88
- EVCM 14.15
- 52 Week Low
- CNTA $9.60
- EVCM $8.10
- 52 Week High
- CNTA $23.24
- EVCM $12.34
- Technical
- Relative Strength Index (RSI)
- CNTA 71.02
- EVCM 60.35
- Support Level
- CNTA $15.01
- EVCM $11.23
- Resistance Level
- CNTA $23.24
- EVCM $11.75
- Average True Range (ATR)
- CNTA 1.23
- EVCM 0.31
- MACD
- CNTA 0.59
- EVCM 0.04
- Stochastic Oscillator
- CNTA 82.62
- EVCM 84.62
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
About EVCM EverCommerce Inc.
EverCommerce Inc provides tailored Software-as-a-Service solutions for service-based small- and medium-sized businesses (SMBs) in-home services, health services, and fitness & wellness. With a platform serving approximately 708,000 customers across three core verticals, including numerous micro-verticals, their solutions address diverse needs within these sectors. Revenue is mostly generated from the United States. Operating in a single segment, their vertically-tailored SaaS offerings cater to SMBs' specialized demands, enabling them to automate processes, generate business, and enhance customer loyalty. The majority of customers contribute modest revenue, with a small percentage contributing higher amounts.